Answers are grounded in this paper and cite their sources.
Multi-omics data integration provides rich complementary information for cancer survival prediction, yet modality incompleteness is pervasive in real-world medical data and undermines the stability and applicability of existing models. To address this challenge, we propose DMG-PoE, a robust learning framework for multi-omics survival prediction. The framework introduces a dynamic modality graph (DMG) that propagates complementary information across modality nodes to compensate for missing inputs, combined with an uncertainty-aware product-of-experts (PoE) fusion mechanism that adaptively weights each modality by its estimated precision, and a consistency-constrained training strategy that stabilizes predictions across varying modality subsets. Systematic evaluation on the SurvBoard benchmark across 10 TCGA cancer types and seven omics modalities demonstrates that DMG-PoE achieves the highest average C-index under both the standard setting (complete-modality training/testing) and the missing-augmented setting (training additionally includes real incomplete samples and nonclinical modality dropout, with complete-only testing); controlled per-modality masking experiments validate effective test-time recovery in 22/24 cancer-modality combinations, and cross-cohort transfer with only two of seven modalities available further confirms generalization under severe input restriction.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: